Dillon & Associates Inc Amgen Inc Transaction History

Dillon & Associates Inc

$637 Million
Q1 2024

A detailed history of Dillon & Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Dillon & Associates Inc holds 2,616 shares of AMGN stock, worth $813,262. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,616

Previous 2,616 -0.0%

Holding current value

$813,262

Previous $753,000 1.33%

% of portfolio

0.12%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $767 - $865	-3 Reduced 0.11%	2,616 $753,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1,093 - $1,357	-5 Reduced 0.19%	2,619 $705,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $67,737 - $82,560	-300 Reduced 10.26%	2,624 $635,000
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $33,868 - $41,280	150 Added 5.41%	2,924 $706,000
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 1.77%	2,774 $674,000

Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 3.42%	2,824 $683,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $23,865 - $27,312	120 Added 4.28%	2,924 $658,000
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $6,368 - $7,461	-30 Reduced 1.06%	2,804 $597,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 1.73%	2,834 $706,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $21,638 - $25,767	-100 Reduced 3.35%	2,884 $663,000
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $10,559 - $11,742	45 Added 1.53%	2,984 $758,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 1.67%	2,939 $694,000
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $28,381 - $36,480	-150 Reduced 4.78%	2,989 $720,000
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $16,605 - $18,651	-100 Reduced 3.09%	3,139 $581,000
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $50,829 - $59,400	-300 Reduced 8.48%	3,239 $551,000
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $33,458 - $38,200	-200 Reduced 5.35%	3,539 $658,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,739	3,739 $643,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account

Dillon & Associates Inc Amgen Inc Transaction History